Market Overview

Cell Microsystems Announces First Commercial Sale of Automated AIR™ System for Single Cell Imaging, Sorting and Isolation

Share:

Cell Microsystems, a provider of innovative tools and scalable solutions
for the sorting and isolation of single cells, announced today the first
commercial sale of its automated AIR™ System for the imaging, sorting
and isolation of single cells and small colonies. Albert Einstein
College of Medicine investigator Jan Vijg, PhD, acquired the system as a
component of Einstein's already extensive core facilities and their
recent foray into single cell genomic technology.

The company's CEO, Gary Pace, PhD, JD, described the accomplishment
saying, "Having a world-class team like Dr. Vijg's at Einstein as the
first purchaser of the AIR™ System is excellent validation of the
product's capabilities, value and commercial potential. We look forward
to continuing our collaborative relationship with their team and others
as we continue to enhance the capabilities of the AIR™ System."

The AIR™ System is based on the core CellRaft™ Technology which allows
single cells to be cultured in an array of thousands of microwells
contained in the proprietary CytoSort™ Array consumable. After imaging
each cell using the system's 3-channel fluorescence and brightfield
capabilities, users can select cells for subsequent isolation and
downstream molecular analysis or culture of clonal colonies. The system
is generally utilized by researchers focused on single cell genomic
analysis or genome editing methods such as CRISPR.

Moonsook Lee, MS, Laboratory Manager in the Vijg lab, described the AIR™
System as, "very useful to pick single cells and nuclei. It works very
well even with very small collection volumes of 1 and 2.5 microliters."

The system is also being used in neighboring laboratories for its
capabilities to isolate clonal colonies in genome editing workflows.
Yizhou Zhu, a graduate student in the laboratory of Yousin Suh, PhD,
observed the AIR™ System's unique capabilities, saying, "the system
really allows us to do imaging-based characterization of genome edited
cells that we otherwise couldn't do. We are very excited to have the
AIR™ at Einstein and have a lot of experiments planned for it."

Cell Microsystems' Director of Product Applications and Market
Development, Nick Trotta, PhD, indicated that the remainder of 2018 and
beyond will be an exciting time for both the company and the underlying
technology. "We are seeing a lot of enthusiasm for the AIR™ System in a
lot of different markets, including single cell genomics, CRISPR, drug
screening, therapeutic protein manufacturing and even diagnostics. It
seems that every sector of life science research is eager for a
flexible, easy-to-use single cell isolation platform and the AIR™ System
meets or exceeds many of the key criteria."

The company was recently listed as one of the top awardees of NIH
funding in the state of North Carolina and will be exhibiting its
products at upcoming life science conferences including the American
Society for Human Genetics and the joint American Society for Cell
Biology/European Molecular Biology Organization, both in San Diego later
in 2018.

About Cell Microsystems

Cell Microsystems is an early growth stage company that develops,
manufactures, and markets innovative products for single cell biology.
The Company's proprietary CellRaft™ Technology enables high-efficiency
sorting and isolation of single cells under standard culture conditions
resulting in unperturbed phenotypes and high viability. Coupled with the
Company's automated imaging platform, a user can select a cell in
real-time and ‘track and trace' that cell through imaging, collection
and downstream analysis. By sorting during real-time imaging, no cells
are wasted enabling single cell isolation from even small, precious
samples. The CellRaft Technology offers scalable solutions making cell
separation technology available for every lab. For more information,
visit: https://cellmicrosystems.com/.

View Comments and Join the Discussion!